Filing Flows › Companies › Alnylam Pharmaceuticals › Earnings quality
Alnylam Pharmaceuticals earnings quality score
How much of the reported profit is backed by cash, and how many markers of managed earnings the filings show
Score59 / 100 · grade C · rank 716 of 1027
Alnylam Pharmaceuticals (ALNY) scores 59 of 100 for earnings quality, grade C: rank 716 of 1027 companies and 81 of 126 in health. It loses the most points on Montier C-score 4 of 5 checks failed, accruals of -4.6% of assets, lower than 55% of companies (profit backed by cash), Beneish M-score -1.98: in the grey zone. It earns full or near-full marks for Dechow F-score 0.37 (normal), profit about as variable as cash flow (smoothness 1.21).
What earned and lost points
| Component | What the filings show | Points | Of |
|---|---|---|---|
| Accruals | accruals of -4.6% of assets, lower than 55% of companies (profit backed by cash) | 12 | 22 |
| Beneish M-score | Beneish M-score -1.98: in the grey zone | 8 | 17 |
| Dechow F-score | Dechow F-score 0.37 (normal) | 17 | 17 |
| Montier C-score | Montier C-score 4 of 5 checks failed | 3 | 17 |
| Discretionary accruals | discretionary accruals of -2.4% of assets (modified Jones), smaller than most | 7 | 11 |
| Piotroski F-score | Piotroski F-score 6 of 9 | 7 | 11 |
| Earnings smoothness | profit about as variable as cash flow (smoothness 1.21) | 6 | 6 |
How the score is built
Eight published measures, each scored against the whole universe or on its own scale and weighted: accruals 20, discretionary accruals 10, Beneish M 15, Dechow F 15, Montier C 15, Piotroski F 10, the non-GAAP gap 10, smoothness 5. A measure that cannot be computed (Beneish for a bank, say) drops out and the rest is rescaled, so every company is scored on what applies to it.
Every company ranked → The full quality workbench, live → Alnylam Pharmaceuticals: cash flow →
Computed from the companies’ own XBRL filings (latest fiscal year) by published formulas; a statistical screen, not an audit or an accusation. A low score means the reported profit shows more of the markers of managed or low-quality earnings than its peers. Not investment advice.